Dr. Hollis R. Chaney

Dr. J. Michael Collaco is a professor of pediatrics at the Johns Hopkins University School of Medicine. His clinical specialty is pediatric pulmonary medicine, including chronic lung disease of premature infants, lung disease in medically complex patients including ventilators and tracheostomies, hereditary hemorrhagic telangiectasia, aerodigestive disorders, and general pediatric pulmonary conditions. He sees patients inpatient and outpatient at Johns Hopkins (East Baltimore campus), inpatient and outpatient at Mount Washington Pediatric Hospital, and inpatient at Kennedy Krieger Institute. Dr. Collaco attended Yale University for undergraduate studies and received his M.D. and M.S. (Anatomy) from Case Western University School of Medicine in Cleveland, Ohio. He completed his pediatric residency, pediatric pulmonary fellowship, M.B.A., M.P.H., and Ph.D. (Clinical Epidemiology) at the Johns Hopkins University. Dr. Collaco joined the Johns Hopkins faculty in 2008. His primary research interest is in the epidemiology of pediatric respiratory diseases, with a focus on environmental risk factors for cystic fibrosis and bronchopulmonary dysplasia as well as a special interest in the effects of secondhand smoke and electronic cigarette emissions. He has published over 140 peer-reviewed articles. Dr. Collaco is a member of the Cystic Fibrosis Research Development Center and the Hereditary Hemorrhagic Telangiectasia Center of Excellence. He has been recognized by Johns Hopkins with the John C. Hume Scholarship, the Francis F. Schwentker Research Award, and the Robert Dyar Award. Dr. Collaco is a fellow of the American Academy of Pediatrics. Dr. Collaco is rated as a Distinguished provider by MediFind in the treatment of Pseudomonas Stutzeri Infections. His top areas of expertise are Bronchopulmonary Dysplasia, Cystic Fibrosis, Pulmonary Hypertension, Pseudomonas Stutzeri Infections, and Gastrostomy.

Anastassios Koumbourlis is a Pediatric Pulmonologist and a Pediatrics provider in Washington, Washington, D.c.. Dr. Koumbourlis is rated as an Advanced provider by MediFind in the treatment of Pseudomonas Stutzeri Infections. His top areas of expertise are Cystic Fibrosis, Asthma, Tracheoesophageal Fistula, and Ciliary Dyskinesia-Bronchiectasis.

Dr. Peter Mogayzel is the Menowitz/Rosenstein Professor of Pediatric Respiratory Sciences at the Johns Hopkins University School of Medicine. His areas of clinical expertise include pediatric pulmonary medicine and the treatment of cystic fibrosis. He has served as the director of the Johns Hopkins Cystic Fibrosis Center since 2002. Dr. Mogayzel attended Brown University and received his M.D. and Ph.D. degrees from Boston University and an M.B.A. from Johns Hopkins University. He completed his pediatric residency at the University of Washington, and finished pediatric pulmonary and pediatric critical care fellowships at Johns Hopkins in 1998 before joining the faculty. His research interests include the regulatory properties of the CFTR gene, mucociliary clearance and development of new therapeutics for cystic fibrosis. Dr. Mogayzel has provided care for children with cystic fibrosis and has been active in the CF community since his arrival at Johns Hopkins. He served as Chairman of the Clinical Practice Guidelines for Pulmonary Therapies Committee and the Therapeutic Development Network Protocol Review Committee both of the Cystic Fibrosis Foundation. He is also a past Chairman of the Cystic Fibrosis Foundation Center Committee which accredits cystic fibrosis care centers in the US. He is currently a member of the Board of Directors of the Cystic Fibrosis Foundation. Dr. Mogayzel is rated as an Advanced provider by MediFind in the treatment of Pseudomonas Stutzeri Infections. His top areas of expertise are Cystic Fibrosis, Secondary Immunodeficiency (SID), Newborn Jaundice, and Pseudomonas Stutzeri Infections.